220 related articles for article (PubMed ID: 18490667)
21. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Tong JL; Ran ZH; Shen J; Xiao SD
J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
[TBL] [Abstract][Full Text] [Related]
22. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy.
Gatta L; Vakil N; Vaira D; Scarpignato C
BMJ; 2013 Aug; 347():f4587. PubMed ID: 23926315
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials.
Biswas DP; Tk DS
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101832. PubMed ID: 34775122
[TBL] [Abstract][Full Text] [Related]
24. Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection.
Alsohaibani F; Al Ashgar H; Al Kahtani K; Kagevi I; Peedikayil M; Alfadda A; Khan M
Saudi J Gastroenterol; 2015; 21(4):220-5. PubMed ID: 26228365
[TBL] [Abstract][Full Text] [Related]
25. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.
Scaccianoce G; Hassan C; Panarese A; Piglionica D; Morini S; Zullo A
Can J Gastroenterol; 2006 Feb; 20(2):113-7. PubMed ID: 16482238
[TBL] [Abstract][Full Text] [Related]
27. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
Lee JW; Kim N; Kim JM; Nam RH; Kim JY; Lee JY; Lee DH; Jung HC
Scand J Gastroenterol; 2014 Aug; 49(8):917-24. PubMed ID: 24988873
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
Horvath A; Dziechciarz P; Szajewska H
Aliment Pharmacol Ther; 2012 Sep; 36(6):534-41. PubMed ID: 22827718
[TBL] [Abstract][Full Text] [Related]
29. Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection: An Updated Systematic Review.
Feng L; Wen MY; Zhu YJ; Men RT; Yang L
Am J Ther; 2016; 23(3):e880-93. PubMed ID: 25569598
[TBL] [Abstract][Full Text] [Related]
30. [Ten-day sequential therapy for Helicobacter pylori eradication in children: a systematic review of randomized controlled trials].
He JD; Liu L; Zhu YJ
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3500-5. PubMed ID: 24521889
[TBL] [Abstract][Full Text] [Related]
31. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.
Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC
Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592
[TBL] [Abstract][Full Text] [Related]
32. Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting?
Boal Carvalho P; Magalhães J; Dias de Castro F; Rosa B; Cotter J
Acta Med Port; 2017 Mar; 30(3):185-189. PubMed ID: 28550827
[TBL] [Abstract][Full Text] [Related]
33. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
[TBL] [Abstract][Full Text] [Related]
34. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S
Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145
[TBL] [Abstract][Full Text] [Related]
35. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
[TBL] [Abstract][Full Text] [Related]
37. Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial.
Lee H; Kim BJ; Kim SG; Kim JI; Choi IJ; Lee YC; Kim JG; Kim JJ;
Trials; 2017 Nov; 18(1):549. PubMed ID: 29149904
[TBL] [Abstract][Full Text] [Related]
38. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
39. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
